Briefings on Accreditation and Quality There was a far-ranging medication management discussion held at The Joint Commission’s 2019 Executive Briefings this September. Led by Robert Campbell, PharmD, a pharmacist with The Joint Commission’s Standards Interpretation Group, the panel covered everything from medication compounding, opioids and painkillers, and syringe use.  The Joint Commission (TJC) is revising five elements of performance (EP) following a CMS review of TJC’s EP Review Project for its Leadership (LD) chapter. The revisions go into effect starting January 1, and deal with the deeming in hospitals and critical access hospitals to better align with CMS' Conditions of Participation (CoP).
Marketing Spotlight Presented on: Wednesday, December 12 2018 |1:00-2:30 p.m. EST
Presented by: Kurt A Patton, MS, RPh.
Register: https://hcmarketplace.com/preliminary-denial-of-accreditation
When the Joint Commission hands out a Preliminary Denial of Accreditation (PDA) decision, you have a small window to set things right. If you can’t get your hospital to band together to fix the problem, a PDA can cost you your accreditation, reputation, and ability to treat patients. And that’s before CMS gets involved. Join former Joint Commission surveyor Kurt Patton, MS, RPh, this August as he reviews how you might get a PDA, what you can do about it, and what surveyors will expect during their follow-up.
Editor's Picks November 27, 2018
Is All of Your Team In The Know? Our weekly e-newsletters can keep your team abreast of up-to-date industry information; including expert analysis where you need it most. Subscribe to any -- or all -- of our e-newsletters. |
